Dr. Christina A. Dilaveri, MD

Dr. Dilaveri practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Dilaveri's NPI, 1194705954, was assigned on January 18, 2006. Dr. Dilaveri graduated from University of Kansas School of Medicine - Kansas City in 2004. Dr. Dilaveri holds Minnesota license 47889.

Dr. Dilaveri's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Dilaveri's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Dilaveri is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Dilaveri to 1 more clinical lab and 1 hospice, each named with a free account. Dr. Dilaveri's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dilaveri practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dilaveri's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dilaveri is board certified in internal medicine by the American Board of Internal Medicine. Dr. Dilaveri is licensed in Minnesota.

Dmand AI lists acid reflux, arthritis, atrial fibrillation and flutter, benign or precancerous skin growths, chronic diabetes, chronic hypertension, chronic nasal allergies and chronic sinusitis among the conditions Dr. Dilaveri treats.

CMS data shows 226 Medicare services from Dr. Dilaveri across 5 procedure codes in 2024, for 145 Medicare patients. Medicare paid $19,592 for them. Every service was in an office.

CMS counts 145 Medicare patients who saw Dr. Dilaveri in 2024. The largest group is 65 to 74, with 88 patients. 74% of them have high cholesterol, and 59% have cancer. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dilaveri's median patient age at 67, with 83% women.

In 2024, Dr. Dilaveri wrote 525 Medicare Part D claims for 99 patients. 89% of them were for generic drugs. CMS names the drug for 197 of them, across 9 drugs with 11 or more claims each, at $7,971 in total drug cost. In 2023, CMS named 294 claims across 15 drugs.

Dr. Dilaveri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dilaveri as offering telehealth.

Dmand AI links 19 papers to Dr. Dilaveri, published from 2011 to 2025. 2011 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Breast and Diagnosis, Differential. Dr. Dilaveri has published most often in Int J Womens Health. Dr. Dilaveri's most frequent co-authors are Karthik Ghosh, MD, Tina J. Hieken, MD and Nicole Punkay Sandhu, MD.

CMS Open Payments shows 1 general payment to Dr. Dilaveri from 1 drug or device company in 2025. Education make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $43.

Dr. Dilaveri serves on Medical Grand Rounds, Ask Mayo Expert Content Review Board and Faculty Development Committee.

Dr. Dilaveri graduated from University of Kansas School of Medicine - Kansas City in 2004. Dr. Dilaveri is a member of ACP, AMA, American Society of Breast Disease, Minnesota Medical Association and Zumbro Valley Medical Society.

Dr. Dilaveri is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Medica. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.